Tao Synergies Inc (TAOX) Stock Price, Quote & News

Company Profile

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.

Industry: Capital Markets

Sector: Financial Services

Phone: 973 242 0005

Website: taosynergies.com

Address:

1185 Avenue of the Americas, 3rd Floor, New York, United States

show_me_the_money_Adam Aug. 5 at 7:17 PM

$TAOX Added more today

0 · Reply

EndGame1 Aug. 5 at 4:01 PM

$TAOX It's really trying, but can $TAO.X just break $200 /coin and never look back!

0 · Reply

SnoopyPotter Aug. 5 at 2:47 AM

$TAOX tao should be back at $500 in the fall

1 · Reply

Jimmybelanger3 Aug. 4 at 6:14 AM

$TAOX let’s go to the moon

0 · Reply

cor1 Aug. 4 at 12:47 AM

$TAO.X $TAOX

1 · Reply

cor1 Aug. 4 at 12:45 AM

$TAOX

0 · Reply

cor1 Aug. 4 at 12:45 AM

$TAOX

0 · Reply

cor1 Aug. 4 at 12:45 AM

$TAO.X $TAOX

0 · Reply

EndGame1 Aug. 3 at 5:08 PM

$TAOX Congrats to those that believe in $TAO.X . I haven’t sold any $TAOX for a year now. Down but will recover. Soon $4 and then much higher…imo.

0 · Reply

Jimmybelanger3 Jul. 31 at 5:19 AM

$TAOX stock trades like it’s on crack

1 · Reply

TAO Synergies appoints Jeffrey as an advisor to the Company

Jul 8, 2026, 9:15 AM EDT - 4 weeks ago

TAO Synergies Appoints Bittensor Investor and Author Mark Jeffrey as Advisor

2026-06-16T13:21:36.000Z - 7 weeks ago

TAO Synergies to join the Russell Microcap Index

Jun 16, 2026, 9:15 AM EDT - 7 weeks ago

TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI

Nov 18, 2025, 5:15 PM EST - 9 months ago

Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

BEX CSEX NNEX SNPX

Nov 18, 2025, 9:15 AM EST - 9 months ago

TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

Nov 13, 2025, 6:46 AM EST - 9 months ago

Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys

BEX CSEX NNEX SNPX

2025-11-12T21:22:16.000Z - 9 months ago

TAO Synergies files to sell 22.3M shares of common stock for holders

Nov 11, 2025, 11:26 AM EST - 9 months ago

Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

BEX CSEX NNEX SNPX

2025-11-04T14:20:39.000Z - 9 months ago

TAO Synergies announces initial $750K investment in Bittensor Subnet Funds

Nov 4, 2025, 9:15 AM EST - 9 months ago

TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

2025-10-20T13:20:22.000Z - 10 months ago

TAO Synergies reports total TAO increased to 54,058 tokens

Oct 20, 2025, 9:15 AM EDT - 10 months ago

TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

2025-10-13T21:15:14.000Z - 10 months ago

TAO Synergies announces $11M private placement

Oct 13, 2025, 5:09 PM EDT - 10 months ago

TAO Synergies Announces $11 Million Private Placement

Sep 22, 2025, 9:15 AM EDT - 11 months ago

TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

Sep 8, 2025, 9:15 AM EDT - 11 months ago

TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event

Aug 26, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy

2025-08-14T20:55:13.000Z - 1 year ago

TAO Synergies files $100M mixed securities shelf

2025-07-17T13:21:08.000Z - 1 year ago

TAO Synergies acquires $10M of Bittensor

2025-07-11T21:05:08.000Z - 1 year ago

TAO Synergies files to sell 5.04M shares of common stock for holders

Jul 1, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today

Jun 26, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy

Jun 24, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Jun 9, 2025, 9:00 AM EDT - 1 year ago

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Dec 20, 2024, 9:15 AM EST - 1 year ago

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Sep 11, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces $5.0 Million Financing

Jul 18, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Jun 26, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

May 7, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery

Apr 24, 2024, 9:15 AM EDT - 2 years ago

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Dec 19, 2023, 9:00 AM EST - 2 years ago

Synaptogenix President Daniel L. Alkon, M.D.

Dec 6, 2023, 9:00 AM EST - 2 years ago

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Nov 2, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology

Sep 26, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease

Sep 7, 2023, 9:00 AM EDT - 3 years ago

Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

Jul 19, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

Jul 13, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience

Mar 7, 2023, 9:00 AM EST - 3 years ago

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

Dec 16, 2022, 9:00 AM EST - 3 years ago

Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

Nov 18, 2022, 9:00 AM EST - 4 years ago

Synaptogenix Announces $15 Million Private Placement with Existing Investors

Oct 19, 2022, 9:00 AM EDT - 4 years ago

Synaptogenix to Present at ThinkEquity Investor Conference on October 26, 2022

Sep 28, 2022, 11:50 AM EDT - 4 years ago

Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

Aug 12, 2022, 9:00 AM EDT - 4 years ago

Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

Jul 26, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

Jul 21, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Corporate Update Conference Call

Jul 20, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data

May 17, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at the Cell Symposium

Apr 19, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Completes Patient Enrollment in NIH Sponsored Phase 2b Alzheimer's Disease Trial

Apr 5, 2022, 9:15 AM EDT - 4 years ago

New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix's Bryostatin for Alzheimer's Disease

Mar 29, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit

Mar 22, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum

Mar 15, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present Research Highlighting Potential Broad Applicability for Lead Compound Bryostatin at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

Feb 23, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Feb 1, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients

Sep 10, 2021, 9:00 AM EDT - 5 years ago

Synaptogenix Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 5, 2021, 10:00 AM EDT - 5 years ago

Synaptogenix Signs Memorandum Of Understanding with Nemours A.I. DuPont Hospital to Initiate Trial Using Bryostatin, Under Orphan Drug Status, to Treat Fragile X Syndrome

Jul 26, 2021, 9:15 AM EDT - 5 years ago

Synaptogenix Discloses Positive Results of Further Bryostatin Trial Analyses in Presentation at Alzheimer's Association International Conference 2021

show_me_the_money_Adam Aug. 5 at 7:17 PM

$TAOX Added more today

0 · Reply

EndGame1 Aug. 5 at 4:01 PM

$TAOX It's really trying, but can $TAO.X just break $200 /coin and never look back!

0 · Reply

SnoopyPotter Aug. 5 at 2:47 AM

$TAOX tao should be back at $500 in the fall

1 · Reply

Jimmybelanger3 Aug. 4 at 6:14 AM

$TAOX let’s go to the moon

0 · Reply

cor1 Aug. 4 at 12:47 AM

$TAO.X $TAOX

1 · Reply

cor1 Aug. 4 at 12:45 AM

$TAOX

0 · Reply

cor1 Aug. 4 at 12:45 AM

$TAOX

0 · Reply

cor1 Aug. 4 at 12:45 AM

$TAO.X $TAOX

0 · Reply

EndGame1 Aug. 3 at 5:08 PM

$TAOX Congrats to those that believe in $TAO.X . I haven’t sold any $TAOX for a year now. Down but will recover. Soon $4 and then much higher…imo.

0 · Reply

Jimmybelanger3 Jul. 31 at 5:19 AM

$TAOX stock trades like it’s on crack

1 · Reply

SnoopyPotter Jul. 31 at 12:24 AM

TAOX got a tweet reply back from jay altucher “Well, $TAOX owns not just TAO tokens (I think 82,000 but not sure) but also alpha tokens and has other business initiatives in AI happening.”

1 · Reply

show_me_the_money_Adam Jul. 30 at 5:09 PM

$TAOX Added!

0 · Reply

SnoopyPotter Jul. 29 at 7:33 PM

$TAOX come on Tao- go mainstream

0 · Reply

DATCAP Jul. 28 at 7:46 PM

$TAOX quietly increased holdings per share (HPS) after quarter-end. Company-stated holdings rose from approximately 82.2K TAO on March 31 to approximately 82.8K on May 13, while common shares remained 7.472M. Using those approximate endpoints, TAO per share improved about 0.7% without common-share dilution. That is the cleanest form of treasury growth: more TAO on the same denominator. Holdings are company-stated approximations, not exact. May 13 is the latest primary-source holdings and share update. Cash, debt and preferred equity remain dated March 31, with no fresher primary source.

0 · Reply

EndGame1 Jul. 28 at 1:37 AM

$TAOX It's in trouble. "JUST IN: NY ATTORNEY GENERAL LETITIA JAMES JUST DEMANDED CONGRESS BLOCK THE #BITCOIN CLARITY ACT SHE CLAIMS IT WOULD “NEUTER STATE AND LOCAL LAW ENFORCEMENT” “INTERFERE WITH AND PREEMPT STATES’ INVESTOR PROTECTION LAWS” AND “DILUTE OUR ABILITY TO PROSECUTE FRAUD” SHE’S DEFENDING THE SAME BROKEN SYSTEM THAT LET HUNDREDS OF BILLIONS VANISH FROM AMERICAN CONSUMERS THIS IS EXACTLY WHY WE NEED CRYPTO CLARITY PASS IT NOW"

0 · Reply

EndGame1 Jul. 28 at 1:24 AM

$TAOX Crypto is getting smashed again.

0 · Reply

EndGame1 Jul. 27 at 2:05 PM

$TAOX And Barry Silbert @ BarrySilbert "Jason gets it. He’s early in the next big thing, like usual Don’t sleep on Bittensor." $TAO.X

0 · Reply

EndGame1 Jul. 27 at 1:50 PM

$TAOX Mark Jeffrey too... "NVIDIA is paying attention to Bittensor $TAO.X Out of 33 total companies, 7 subnets were accepted into NVIDIA Inception. That's 21%. Actual (SN95), Targon (SN4), Trishool (SN23), Score (SN44), Nephro Robotics (SN49), and Leadpoet (SN71). @ zipcodenetwork

0 · Reply

EndGame1 Jul. 27 at 1:38 PM

$TAOX May be our week. A lot of Bittensor talk over the weekend from whales. Jason Calacanas tweeted... "I'm so obsessed with the @ bittensor model, where competing for prizes is vetted by validators... open source, OPEN COMPETITION, is the future!" "If @ JensenHuang knows what @ bittensor is, and NVIDIA is engaging them on any level, that's worth watching."

0 · Reply

topstockalerts Jul. 27 at 11:20 AM

Pre Market Top Gainers PT2 $TRAX $SXTC $VEEE $AIMD $TAOX

0 · Reply

EndGame1 Jul. 24 at 4:24 PM

$TAOX Price is being crushed. I don’t get it, with so much $TAO.X potential.

0 · Reply

SnoopyPotter Jul. 22 at 5:21 PM

$TAOX when are investors coming ? everyone realizes there isn’t enough so puts gpu from centralized ai.

1 · Reply

Market Cap	26.08M
Revenue (ttm)	300,000.00
Net Income (ttm)	-28.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,580.00%
Debt to Equity Ratio	0.00

Volume	35,929
Avg Vol	103,996
Day's Range	N/A - N/A
Shares Out	7.47M
Stochastic %K	37%
Beta	1.45
Analysts	Strong Buy
Price Target	N/A